Menú Close

Artículos sobre AstraZeneca

Mostrando 1 - 20 de 73 artículos

The AstraZeneca vaccine was 70 per cent effective against symptomatic COVID-19 infection in a large multinational study, and recently reported 76 per cent overall efficacy against symptomatic COVID-19 in another large study done primarily in the United States. THE CANADIAN PRESS/John Woods

AstraZeneca COVID-19 vaccine FAQ: Why do the age recommendations keep changing? Does it cause VIPIT blood clots? Is it effective against variants?

With changing recommendations about AstraZeneca's COVID-19 vaccine making headlines, many people have questions about its use.
A healthcare worker administers an Oxford/AstraZeneca COVID-19 vaccine to her colleague at Mutuini Hospital in Nairobi. Kenya on March 3, 2021. Photo by Dennis Sigwe/SOPA Images/LightRocket via Getty Images

Kenya’s COVID-19 vaccine rollout has got off to a slow start: the gaps, and how to fix them

Kenya grapples with two major challenges in the vaccination rollout: access to sufficient doses in light of the global shortage; and vaccine hesitancy.

Principales colaboradores

Más